Absolutely... I mean some patients in the CD-1
Post# of 148184
I mean some patients in the CD-10 trial were "post-COVID" parients (as long as they met the inclusion criteria), but a separate study is justified... perhaps when the m/m results come back positive.
https://www.ajc.com/lifestyles/health/for-som...2y3ezEqcN/